Mark Mossler

Chief Accounting Officer at C4 Therapeutics · 3 reported transactions in 1 company · latest report Feb 14, 2026

Their trades


C4 TherapeuticsCCCC	Shares withheld for tax $6.2K · 3,268 shares	Feb 14, 2026
C4 TherapeuticsCCCC	Exercised options — · 9,420 shares	Feb 14, 2026
C4 TherapeuticsCCCC	Share award — · 56,980 shares	Feb 13, 2026

Shares withheld for taxC4 Therapeutics

Feb 14, 2026 · CCCC

$6.2K

Exercised optionsC4 Therapeutics

Feb 14, 2026 · CCCC

9,420

Feb 13, 2026 · CCCC

56,980

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Accounting Officer at C4 Therapeutics · 3 reported transactions in 1 company · latest report Feb 14, 2026


C4 TherapeuticsCCCC	Shares withheld for tax $6.2K · 3,268 shares	Feb 14, 2026
C4 TherapeuticsCCCC	Exercised options — · 9,420 shares	Feb 14, 2026
C4 TherapeuticsCCCC	Share award — · 56,980 shares	Feb 13, 2026

Shares withheld for taxC4 Therapeutics

Feb 14, 2026 · CCCC

$6.2K

Exercised optionsC4 Therapeutics

Feb 14, 2026 · CCCC

9,420

Feb 13, 2026 · CCCC

56,980

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.